Eyes Turn To Caldicott Review As Big Data Hopes Hit By Care.Data Closure
Executive Summary
The release of two independent reviews on data security in the UK's health and care system have prompted the Conservative government to abandon its NHS care.data database program after years of preparation but which were hampered by worries over data collection.
You may also be interested in...
Care.data fiasco: HSCIC moves into damage limitation mode
The Health and Social Care Information Centre (HSCIC), the body tasked by the National Health Service (NHS) in England to set up the problematic Care.data patient database, has admitted it needs to "improve the transparency of its decision-making and build public trust in its actions."
Anjarium To Pioneer Next-Generation Non-Viral Gene Therapies
Emerging Company Profile: Switzerland-based Anjarium Biosciences AG has successfully raised $61m in a series A financing that will fund expansion of its novel proprietary platform and development of a nascent pipeline of non-viral gene therapies.
Incyte Plays Down Ruxolitinib Cream Label Worries Following Atopic Dermatitis Approval
Incyte welcomed FDA approval of its ruxolitinib cream, a selective JAK1/JAK2 inhibitor, as a treatment for atopic dermatitis, but criticized the boxed warnings label assigned to it.